Almenciol, Fe C.

HRN: 02 65 00  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/01/2023
CEFTAZIDIME 1GM (VIAL)
01/01/2023
01/07/2023
IVT
2 G
Q8h
Cap-mr; Infected Wound , R Breast; Breast Ca
Waiting Final Action 

Indication:  Empiric    Type of Infection:  PneumoniaSkin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: